TRIM25 and neoplasm: Meanwhile, compared with the siNC plus PTX group, TRIM25 knockdown significantly increased the anti-tumor effect of PTX, and restoring BRD7 expression could significantly reverse the effect of TRIM25 knockdown on paclitaxel chemotherapy (Fig. 7A–C, S9B).